NCT01895205

Treatment of Women After Severe Postpartum Haemorrhage

A Randomized Comparative, Open-Label Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by High Single Dose In-fusions or Red Blood Cell Transfusion in Women With Severe Postpartum Iron Deficiency Anaemia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 13 (actual)
• Sponsor: Pharmacosmos A/S · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary purpose of this study is to get explorative information about IV high single dose infusion of iron isomaltoside 1000 compared to RBC transfusion in the treatment of severe PP-IDA evaluated as physical fatigue

Conditions

• Severe Postpartum Haemorrhage

Interventions

Type	Name	Description
DRUG	Iron isomaltoside 1000
DRUG	Red blood cell transfusion

Timeline

• Start date: 2013-06-01
• Primary completion: 2015-08-01
• Completion: 2015-08-01
• First posted: 2013-07-10
• Last updated: 2015-08-19

Locations

1 site across 1 country: Denmark